bioelectronic-medicine
(3)
Coherence Neuro
Coherence Neuro is a San Francisco medical-device company building closed-loop neurotechnology to treat cancer as a continuously monitored condition rather than a reactive battle. Founded in 2022 by University of Cambridge researchers Ben Woodington and Elise Jenkins, the company decodes the body's electrical signals in real time and delivers adaptive, AI-tuned stimulation through its flagship SOMA system - a wireless implant, wearable, and mobile app working together. Backed by a $10M seed round led by Artesian and Topology Ventures, Coherence aims to begin first-in-human trials in 2026.
NeuroBionics
NeuroBionics is a Boston-area neurotechnology company spun out of more than a decade of MIT research. It builds hair-thin, flexible bioelectronic fibers that reach neural targets through the body's blood vessels instead of open surgery. Its lead device, evStim, aims to deliver deep brain and peripheral nerve stimulation endovascularly, potentially widening access to neuromodulation therapy for conditions like Parkinson's disease, epilepsy, chronic pain, and depression.
SecondWave Systems, Inc.
SecondWave Systems is a Minneapolis medical device company pioneering bio-ultrasonic medicine: a noninvasive, wearable ultrasound platform that targets the spleen with low-intensity focused ultrasound to calm chronic inflammation - offering patients with conditions like rheumatoid arthritis a drug-free alternative to biologics. Founded in 2019 by Anuj Bhardwaj, Hubert Lim, and Jeff Heyman, it builds on ultrasound expertise from the family-founded Ultran Group and over $15M in non-dilutive government support from DARPA, NIH, and ARPA-H.